Clinical Trial Update: Therapeutic Drug Monitoring of Sunitinib and Pazopanib in Advanced or Metastatic Renal Cell Carcinoma [Phase 4]

View source ↗

Summary

This is a Phase 4 clinical trial update evaluating therapeutic drug monitoring of sunitinib and pazopanib in advanced or metastatic renal cell carcinoma. The st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)
• Votrient (Pazopanib)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Metastatic Renal Cell Cancer | Phase 4 | Status: COMPLETED